Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology 3 December 2020 | Press release
We are excited to announce Artios has moved to brand new labs and offices on the Babraham Research Campus. 20 August 2020 | Announcement
Artios Pharma Strengthens Clinical Development Team with Senior Appointments 10 February 2020 | Press release
Artios attending 38th Annual J.P Morgan Healthcare Conference in San Francisco, January 12-16 2020 9 January 2020 | Announcement
Artios Pharma, MD Anderson and ShangPharma announce in-licensing agreement for DNA damage response inhibitor 6 November 2019 | Press release
Artios Pharma appoints Tania Dimitrova as Chief Business Officer and expands presence in the United States 24 September 2019 | Press release
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer 1 April 2019 | Press release
Artios Pharma Announces Appointment of Professor Rajesh Chopra as Non-Executive Director 11 February 2019 | Press release